Microglia Transcriptional Profiling in Major Depressive Disorder Shows Inhibition of Cortical Gray Matter Microglia
Published version of a preprint
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Scheepstra and colleagues [35], analyzing cortical tissue from individuals with major depressive disorder, reported a transcriptional profile suggestive of microglia exhibiting inhibited or immune-suppressed activity in gray matter rather than a canonical inflammatory phenotype.”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [35]
In the citing paper
“The regional specificity of microglial activation in post-mortem studies, most consistently the anterior cingulate cortex, subgenual prefrontal cortex, hippocampus, and amygdala, maps onto the regions showing functional hyperactivation and structural volume reductions in neuroimaging studies of depression, suggesting that microglial-driven synaptic pruning may contribute to circuit-level Abnormal”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [35]
In the citing paper
“More specific candidate biomarkers, including soluble TREM2 in cerebrospinal fluid and the quinolinic acid-to-kynurenic acid ratio, have shown promise in small studies but require validation in large, prospectively designed biomarker-stratified treatment trials [35, 44].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [35]
In the citing paper
“C-reactive protein, while accessible and clinically established, is a nonspecific acute-phase reactant that imperfectly reflects central microglial activation.”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [35]
In the citing paper
“Brain-derived neurotrophic factor (BDNF) expression is suppressed by pro-inflammatory cytokines, including IL-1beta and TNF-alpha, through NF-kappaB-dependent transcriptional repression of BDNF promoters in cortical and hippocampal neurons, establishing a direct mechanistic link between neuroinflammation and the neurotrophic deficits consistently documented in major depressive disorder [35, 49].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [35]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Microglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973
Self-citationSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature · doi:10.1038/s41586-019-0924-x · Cited by 1,310
Research works printed but not linked: 32
- 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9 · DOI · Paper page
- Mariani, 2021, Gene expression studies in Depression development and treatment: An overview of the underlying molecular mechanisms and biological processes to identify biomarkers, Transl Psychiatry, 11, 354, 10.1038/s41398-021-01469-6 · DOI
- Euesden, 2017, A bidirectional relationship between depression and the autoimmune disorders – New perspectives from the National Child Development Study, PLoS One, 12, 10.1371/journal.pone.0173015 · DOI · Paper page
- Andersson, 2015, Depression and the risk of autoimmune disease: A nationally representative, prospective longitudinal study, Psychol Med, 45, 3559, 10.1017/S0033291715001488 · DOI · Paper page
- Hoogland, 2018, Microglial activation after systemic stimulation with lipopolysaccharide and Escherichia coli, Front Cell Neurosci, 12, 110, 10.3389/fncel.2018.00110 · DOI
- Ramaglia, 2021, Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory, Acta Neuropathol, 142, 643, 10.1007/s00401-021-02338-8 · DOI
- Böttcher, 2020, Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression, Transl Psychiatry, 10, 310, 10.1038/s41398-020-00992-2 · DOI · Paper page
- Snijders, 2021, Distinct non-inflammatory signature of microglia in post-mortem brain tissue of patients with major depressive disorder, Mol Psychiatry, 26, 3336, 10.1038/s41380-020-00896-z · DOI
- Hammond, 2021, Regulation of microglia population dynamics throughout development, health, and disease, Glia, 69, 2771, 10.1002/glia.24047 · DOI
- Sneeboer, 2019, Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated, Transl Psychiatry, 9, 153, 10.1038/s41398-019-0490-x · DOI
- Snijders, 2021, A loss of mature microglial markers without immune activation in schizophrenia, Glia, 69, 1251, 10.1002/glia.23962 · DOI
- Mizee, 2017, Isolation of primary microglia from the human post-mortem brain: Effects of ante- and post-mortem variables, Acta Neuropathol Commun, 5, 16, 10.1186/s40478-017-0418-8 · DOI · Paper page
- Melief, 2012, Phenotyping primary human microglia: Tight regulation of LPS responsiveness, Glia, 60, 1506, 10.1002/glia.22370 · DOI · Paper page
- Leek, 2011, Asymptotic conditional singular value decomposition for high-dimensional genomic data, Biometrics, 67, 344, 10.1111/j.1541-0420.2010.01455.x · DOI
- Wu, 2021, clusterProfiler 4.0: A universal enrichment tool for interpreting omics data, Innovation (Camb), 2
- Carlin, 1980, Isolation and characterization of postsynaptic densities from various brain regions: Enrichment of different types of postsynaptic densities, J Cell Biol, 86, 831, 10.1083/jcb.86.3.831 · DOI · Paper page
- Lehrman, 2018, CD47 protects synapses from excess microglia-mediated pruning during development, Neuron, 100, 120, 10.1016/j.neuron.2018.09.017 · DOI · Paper page
- Barclay, 2002, CD200 and membrane protein interactions in the control of myeloid cells, Trends Immunol, 23, 285, 10.1016/S1471-4906(02)02223-8 · DOI · Paper page
- Elward, 2003, “Eat me” and “don’t eat me” signals govern the innate immune response and tissue repair in the CNS: Emphasis on the critical role of the complement system, Mol Immunol, 40, 85, 10.1016/S0161-5890(03)00109-3 · DOI · Paper page
- Darby, 2016, Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders, Transl Psychiatry, 6, 10.1038/tp.2016.173 · DOI · Paper page
- Miller, 2020, Trial failures of anti-inflammatory drugs in depression, Lancet Psychiatry, 7, 837, 10.1016/S2215-0366(20)30357-6 · DOI
- Li, 2018, Translocator protein (18 kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy, Prog Neuropsychopharmacol Biol Psychiatry, 83, 1, 10.1016/j.pnpbp.2017.12.011 · DOI
- Setiawan, 2018, Association of translocator protein total distribution volume with duration of untreated major depressive disorder: A cross-sectional study, Lancet Psychiatry, 5, 339, 10.1016/S2215-0366(18)30048-8 · DOI · Paper page
- Sneeboer, 2020, Microglial activation in schizophrenia: Is translocator 18-kDa protein (TSPO) the right marker?, Schizophr Res, 215, 167, 10.1016/j.schres.2019.10.045 · DOI
- Koning, 2009, Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions, J Neuropathol Exp Neurol, 68, 159, 10.1097/NEN.0b013e3181964113 · DOI · Paper page
- Feng, 2019, CD200 dysfunction in neuron contributes to synaptic deficits and cognitive impairment, Biochem Biophys Res Commun, 516, 1053, 10.1016/j.bbrc.2019.06.134 · DOI
- Paolicelli, 2011, Synaptic pruning by microglia is necessary for normal brain development, Science, 333, 1456, 10.1126/science.1202529 · DOI · Paper page
- Rimmerman, 2022, Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation, Mol Psychiatry, 27, 1120, 10.1038/s41380-021-01338-0 · DOI
- Basterzi, 2005, IL-6 levels decrease with SSRI treatment in patients with major depression, Hum Psychopharmacol, 20, 473, 10.1002/hup.717 · DOI · Paper page
- Ghareghani, 2017, Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis, Sci Rep, 7, 4923, 10.1038/s41598-017-04968-z · DOI
- Tynan, 2012, A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia, Brain Behav Immun, 26, 469, 10.1016/j.bbi.2011.12.011 · DOI · Paper page
- Faissner, 2017, Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic, Nat Commun, 8, 1990, 10.1038/s41467-017-02119-6 · DOI
Cited by
Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction
Tizabi, Y., Getachew, B., Hauser, S. R., Tsytsarev, V., Manhães, A. C., & da Silva, V. D. A. (2024) · Brain Sciences · doi:10.3390/brainsci14060558 · Cited by 27
Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis
Chen, J. Q. A., McNamara, N. B., Engelenburg, H. J., Jongejan, A., Wever, D. D., Hopman, K., van Rixel, E., Nijhuis, P. J. H., de Winter, F., Moerland, P. D., et al. (2025) · Brain · doi:10.1093/brain/awae414 · Cited by 17
Self-citationMicroglial states revisited: from homeostasis to disease
Eggen, B. J. L., & Kooistra, S. M. (2026) · Nature Reviews Neuroscience · doi:10.1038/s41583-026-01066-w · Cited by 17
Self-citationSanterre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Scheepstra, K. W. F., Mizee, M. R., van Scheppingen, J., Adelia, A., Wever, D. D., Mason, M. R. J., Dubbelaar, M. L., Hsiao, C.-C., Eggen, B. J. L., Hamann, J., & Huitinga, I.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 94
- Issue
- 8
- Pages
- 619-629
- ISSN
- 0006-3223
- Cited by
- 60
- References
- 27
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Nederlandse Hersenbank
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (240–921200)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microglia Transcriptional Profiling in Major Depressive Disorder Shows Inhibition of Cortical Gray Matter Microglia. https://app.cochat.ai/papers/10.1016/j.biopsych.2023.04.020
- The paper
- Scheepstra, K. W. F., Mizee, M. R., van Scheppingen, J., Adelia, A., Wever, D. D., Mason, M. R. J., Dubbelaar, M. L., Hsiao, C.-C., Eggen, B. J. L., Hamann, J., & Huitinga, I. (2023). Microglia Transcriptional Profiling in Major Depressive Disorder Shows Inhibition of Cortical Gray Matter Microglia. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2023.04.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.